Skip to content

Author

D. Tosun

We have 7 of 280 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#small language model Open access Nov 2026

Predicting ARIA incidence due to anti-amyloid therapy for Alzheimer’s disease with multimodal risk modeling frameworks

A framework combining multimodal foundation model architectures (imaging, tabular, vision-language) with ARIA-specific design choices, including prediction heads separating ARIA-E and ARIA-H, severity grading, time-to-event modeling, and APOE-stratified monitoring decisions are proposed, validated through real-world ho...

Jin-Chi Wei, Evan Bloch, Michael Romano et al. · 0 citations
Open access Nov 2026

Age-dependent structural brain aging in medication-free major depressive disorder: A multi-site analysis from COORDINATE-MDD consortium.

BACKGROUND Major depressive disorder (MDD) is associated with altered brain structure and accelerated brain aging. However, previous studies have been limited by clinical samples with mixed medication status and multiple mood states, modest sample sizes, underrepresentation of older adults with MDD, and/or reliance on...

Bhanu Sharma, P. Ballester, L. Minuzzi et al. · 0 citations
Review Open access Jul 2026

Alzheimer's disease heterogeneity and co‐pathologies: Defining novel targets, biomarkers, modalities, and research methodologies

Key takeaways from the Fall 2025 AARR meeting are presented, which brought together academic, clinical, and industry leaders to discuss and explore the current advances in the heterogeneity and co‐pathologies of AD and their implications for diagnosis, clinical trial design, and precision treatment strategies.

M. Tansey, S. Bozeat, Peter Ackerman et al. · 0 citations
Preprint Aug 2026

GenFAR: A generalized representation of brain structure, derived from 49,246 multi-cohort MRIs via deep learning

GenFAR, a modular deep learning framework that learns general, clinically informed features from brain MRIs, is introduced, showing that using the learned feature representation can substantially increase the sample efficiency of secondary deep learning training tasks and models, as well as improve their accuracy.

V. Bashyam, G. Erus, Jun-Hao Wen et al. · 0 citations
Open access Aug 2026

Peripheral blood microarray-based transcriptomic and epigenetic analyses identify immune, inflammation, and metabolic dysregulation in Alzheimer’s disease

Leveraging multi-omics to better understand the molecular signatures and pathways underlying Alzheimer’s disease (AD) pathogenesis is critical for early diagnosis and disease modifying interventions. We performed peripheral blood transcriptome (N = 669) and epigenome microarray analyses (N = 553) on non-Hispanic white...

Brendan A. Mitchell, I. Hausle, Sarah Smith et al. · 0 citations
Open access Jul 2026

Exploring longitudinal relationships among Alzheimer's disease biomarkers

While most studies of Alzheimer's disease (AD) examine cross‐sectional relationships among biomarkers, longitudinal relationships are also highly relevant.

B. Saef, K. K. Petersen, Katherine E. Volluz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.